In a BSE filing, Shasun Pharmaceuticals said, “It has received approval from the United States Food and Drug Administration (US FDA) for Carisoprodol tablets.” The approval is for the 250 mg and 350 mg strengths. Shasun Pharma said Carisoprodol tablets of 250 mg and 350 mg have sales of approximately USD 38 million.
| Subscribe To Our Free Newsletter |
